BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21220773)

  • 1. Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection.
    Yonkers NL; Sieg S; Rodriguez B; Anthony DD
    J Infect Dis; 2011 Mar; 203(5):635-45. PubMed ID: 21220773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naïve CD4+ T Cell Lymphopenia and Apoptosis in Chronic Hepatitis C Virus Infection Is Driven by the CD31+ Subset and Is Partially Normalized in Direct-Acting Antiviral Treated Persons.
    Auma AWN; Shive CL; Lange A; Damjanovska S; Kowal C; Zebrowski E; Pandiyan P; Wilson B; Kalayjian RC; Canaday DH; Anthony DD
    Front Immunol; 2021; 12():641230. PubMed ID: 33912168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
    Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
    Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
    Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
    J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
    Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
    Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CXCR5+ T cells activate CD27+IgG+ B cells via IL-21 in patients with hepatitis C virus infection.
    Kong FY; Feng B; Zhang HH; Rao HY; Wang JH; Cong X; Wei L
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):55-64. PubMed ID: 26818544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group.
    Cacoub P; Musset L; Hausfater P; Ghillani P; Fabiani FL; Charlotte F; Angevin E; Opolon P; Poynard T; Piette JC; Autran B
    Clin Exp Immunol; 1998 Jul; 113(1):48-54. PubMed ID: 9697982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART.
    Shmagel KV; Saidakova EV; Korolevskaya LB; Shmagel NG; Chereshnev VA; Anthony DD; Lederman MM
    AIDS; 2014 Oct; 28(16):2381-8. PubMed ID: 25111083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.
    Cummings KL; Rosen HR; Hahn YS
    Clin Immunol; 2009 Sep; 132(3):401-11. PubMed ID: 19473882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
    Semmo N; Krashias G; Willberg C; Klenerman P
    J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naive and Memory CD4⁺ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART.
    Tanaskovic S; Fernandez S; Saraswati H; Yunihastuti E; Gani RA; Djauzi S; Price P
    Viral Immunol; 2016 Apr; 29(3):176-83. PubMed ID: 27035638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels.
    Bolacchi F; Sinistro A; Ciaprini C; Demin F; Capozzi M; Carducci FC; Drapeau CM; Rocchi G; Bergamini A
    Clin Exp Immunol; 2006 May; 144(2):188-96. PubMed ID: 16634790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distributional characteristics of CD25 and CD127 on CD4+ T cell subsets in chronic HCV infection.
    Shen T; Chen X; Xu Q; Lu F; Liu S
    Arch Virol; 2010 May; 155(5):627-34. PubMed ID: 20204427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease.
    Luciano AA; Lederman MM; Valentin-Torres A; Bazdar DA; Sieg SF
    J Immunol; 2007 Sep; 179(6):3543-9. PubMed ID: 17785788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
    Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
    J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses.
    Moorman JP; Zhang CL; Ni L; Ma CJ; Zhang Y; Wu XY; Thayer P; Islam TM; Borthwick T; Yao ZQ
    Vaccine; 2011 Apr; 29(17):3169-76. PubMed ID: 21376795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin.
    Neau D; Galpérine T; Legrand E; Pitard V; Neau-Cransac M; Moreau JF; Ragnaud JM; Dupon M; Fleury H; Lafon ME
    HIV Med; 2003 Apr; 4(2):120-6. PubMed ID: 12702132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.
    Kuniholm MH; Xie X; Anastos K; Kaplan RC; Xue X; Kovacs A; Peters MG; Seaberg EC; French AL; Young MA; Augenbraun M; Martinson JA; Bush KA; Landay AL; Strickler HD
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):295-303. PubMed ID: 25314250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.